-
Lethbridge submits interest in provincial ground ambulance contract
-
False voting claims spread rapidly during US Election Day
-
The Cat in the Hat expands its stakes to cosmic scale in animated reboot
-
Lettermen co-founder Tony Butala dies at 87
-
Byron Donalds wins Florida governor race and underscores Republican strength
-
James Talarico defeats Ken Paxton in historic Texas Senate result
-
Physicist Claims Alberta Data Center Releases Energy of 23 Atomic Bombs Daily
-
Commentator predicts possible US strike on Iran as regional tensions rise
-
Goa plans relationship-readiness course amid concern over divorces
-
Jordan Bardella's Wealth and Financial Transparency Under Scrutiny
-
Manchester United climbs standings after 3-2 Champions League win over Roma
-
India introduces four-layer motor insurance choice from December 15
-
Mutual fund returns show shifting leaders across market-cap categories
-
How to Make the Most of a Boat Rental Vacation
-
Best Rated Gold IRA Companies 2026 for US Consumers Rankings Released by Experts
-
BHEL wins Adani Power projects valued at up to ₹28,000 crore
-
IndiGo holds talks with Embraer over potential order for 100 aircraft
-
India seeks threefold increase in coal stocks to prevent summer power shortages
-
Indian companies report mixed second-quarter results on November 4
-
Indus Towers expands solar-powered network to 50,000 telecom sites
-
KKR secures Indian regulator approval for Gentari Renewables investment
-
Merz Pledges Winter Aid to Ukraine and Announces 'Coalition of the Willing' Summit
-
Equitas Small Finance Bank rebounds after naming interim chief executive
-
Bharti Airtel revenue expected to grow at double-digit pace in second quarter
-
Titan quarterly profit seen rising as jewellery business drives growth
-
Italy Claims Curling Silver at European Championships in Ostrava
-
Indian crude-sensitive shares gain after 13% oil-price decline
-
Kuwait finance minister holds economic cooperation talks at COMCEC
-
Stocks and dollar fall as Democratic election gains reshape markets
-
Abdul El-Sayed declares victory in Michigan Senate contest
-
Kuwait marks key events and anniversaries from national history
-
Democrats Seize Congress in Midterm Sweep, Ending Trump Era Control
-
Democrats capture US Congress in sweeping midterm victory
-
Trump congratulates Democrats and signals willingness to cooperate
-
Manchester United rallies past Roma as PSG dominates in Champions League
-
Enel to Install Solar Panels at Niterói Waste Management Facility
-
Qatar prime minister advances mediation through diplomatic calls
-
Qatar sees tentative opening for renewed regional diplomacy
-
Greenland parliament approves security agreement with United States
-
Qatar Tourism joins Pacific Asia Travel Association at London travel market
-
Qatar envoy meets incoming UN General Assembly president
-
Abdul El-Sayed Wins Michigan Senate Seat in Historic Election
-
Trump Signals Willingness to Work With Democrats After Midterm Defeat
-
Qatar media bodies discuss support for humanitarian initiatives
US family reaches deal over cells harvested in 1950s
A US biotechnology company has reached a settlement with the family of Henrietta Lacks, an African-American woman whose cells were used for groundbreaking medical research without her consent.
Civil rights attorney Ben Crump, who filed a lawsuit in 2021 on behalf of the Lacks' estate, announced on Tuesday that the family had agreed a confidential deal with Massachusetts-based firm Thermo Fisher Scientific.
"The parties are pleased that they were able to find a way to resolve this matter outside of court," Crump said, noting that Tuesday would have been Lacks' 103rd birthday.
Crump, who has represented the family of George Floyd and other Black victims of US police violence, said the settlement provides "some measure of justice for Henrietta Lacks, 70 years later."
The 31-year-old Lacks, a tobacco farmer from Virginia and mother of five, died of cervical cancer in 1951 at Johns Hopkins Hospital in Baltimore.
During attempts to cure her shortly before she died, Lacks' abnormally resilient cancer cells were removed from her tumor and were used for decades by researchers without her family's knowledge.
The cells, dubbed HeLa for the first letters of her first and last names, were the first-ever human cells to grow endlessly in the lab -- all others harvested up to that point died.
- Nobel Prizes -
Research using the cells led to Nobel Prize-winning discoveries, and laboratories worldwide used them to develop vaccines -- notably against polio -- as well as in cloning, in-vitro fertilization and many medicines, fueling an industry now worth billions of dollars.
The family knew nothing of Lacks' role until the 1970s, and only came to understand its full scope thanks to the work of Rebecca Skloot, author of the 2010 bestseller "The Immortal Life of Henrietta Lacks."
Lacks' story was also the subject of an HBO movie starring Oprah Winfrey.
"They treated her like a specimen, like a lab rat," her grand-daughter Kimberly Lacks said in 2021, describing the cell theft as racism.
Thermo Fisher Scientific confirmed the settlement, using the same language as the family lawyers Crump and Chris Seeger.
In filing the lawsuit in 2021, Seeger said that Thermo Fisher was the first of many companies that could face legal action for having "profited from the use" of the HeLa cells.
On its website, Johns Hopkins Hospital said that it has never sold or benefited from the discovery or distribution of HeLa cells, and does not own the rights to them.
"HeLa cells were offered freely and widely by Johns Hopkins for scientific research," it said.
"Johns Hopkins has worked in close coordination with several members of the Lacks family over the past decade to recognize and honor Henrietta Lacks, including scholarships, engagement with local schools and annual symposia," it added.
Ch.Campbell--AT